Search research articles
Contact Us
Filters
Showing results (341-350 of 369) with videos related to
Page
of 37
Sort By:
Journal of Biological Regulators and Homeostatic Agents
|
July 25, 1998
Physiopathology of IL-12 in human solid neoplasms: blood levels of IL-12 in early or advanced cancer patients, and their variations with surgery and immunotherapy
P Lissoni, S Mengo, M Mandalà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer
S Cascinu, R Labianca, P Alessandroni, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 2, 2025
Geriatric Oncology in Italy. Where we are. A CIPOMO (Italian College of Primary Hospital Medical Oncologists)-Gioger (Italian Group of Geriatric Oncology) Survey
S Barni, A Luciani, P Tralongo, et al.
British Journal of Cancer
|
July 17, 1999
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, R R Silva, S Barni, et al.
British Journal of Cancer
|
April 15, 2004
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, M Scartozzi, R Labianca, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1997
Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) study
S Cascinu, S Barni, R Labianca, et al.
Anticancer Research
|
August 19, 2007
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study
S Barni, M Visini, E Piazza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2010
Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised 'GISCAD' trial
R Labianca, A Sobrero, L Isa, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
February 1, 1997
[Clinical response and survival in metastatic renal carcinoma during subcutaneous administration of interleukin-2 alone. Subcutaneous Il-2 in renal carcinoma]
P Lissoni, S Barni, G Tancini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1997
A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group
E Bajetta, N Zilembo, S Barni, et al.
Page
of 37
Search research articles
Search
Showing results (341-350 of 369) with videos related to
Sort By:
Page
of 37
Journal of Biological Regulators and Homeostatic Agents
|
July 25, 1998
Physiopathology of IL-12 in human solid neoplasms: blood levels of IL-12 in early or advanced cancer patients, and their variations with surgery and immunotherapy
P Lissoni, S Mengo, M Mandalà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer
S Cascinu, R Labianca, P Alessandroni, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 2, 2025
Geriatric Oncology in Italy. Where we are. A CIPOMO (Italian College of Primary Hospital Medical Oncologists)-Gioger (Italian Group of Geriatric Oncology) Survey
S Barni, A Luciani, P Tralongo, et al.
British Journal of Cancer
|
July 17, 1999
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, R R Silva, S Barni, et al.
British Journal of Cancer
|
April 15, 2004
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, M Scartozzi, R Labianca, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1997
Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) study
S Cascinu, S Barni, R Labianca, et al.
Anticancer Research
|
August 19, 2007
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study
S Barni, M Visini, E Piazza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 17, 2010
Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised 'GISCAD' trial
R Labianca, A Sobrero, L Isa, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica
|
February 1, 1997
[Clinical response and survival in metastatic renal carcinoma during subcutaneous administration of interleukin-2 alone. Subcutaneous Il-2 in renal carcinoma]
P Lissoni, S Barni, G Tancini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1997
A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group
E Bajetta, N Zilembo, S Barni, et al.
Page
of 37